| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_XPO1_0011400 | Exon-Exon | chr2:61719170-61727029 | chr2:61492035-61499894 | 1479 nt | 0.3644 |
| hsa_XPO1_0011500 | Exon-Exon | chr2:61719170-61729445 | chr2:61492035-61502310 | 1586 nt | 0.3632 |
| hsa_XPO1_0011600 | Exon-Exon | chr2:61719170-61761038 | chr2:61492035-61533903 | 1893 nt | 0.3671 |
| hsa_XPO1_0013400 | Exon-Exon | chr2:61719702-61724142 | chr2:61492567-61497007 | 807 nt | 0.3656 |
| hsa_XPO1_0013500 | Intron-Exon-Intron | chr2:61719702-61752468 | chr2:61492567-61525333 | 250 nt | 0.3400 |
| hsa_XPO1_0013600 | Exon-Exon | chr2:61719702-61761038 | chr2:61492567-61533903 | 1572 nt | 0.3670 |
| hsa_XPO1_0014700 | Exon-Exon | chr2:61721029-61722748 | chr2:61493894-61495613 | 357 nt | 0.3641 |
| hsa_XPO1_0014800 | Exon-Exon | chr2:61721029-61724142 | chr2:61493894-61497007 | 486 nt | 0.3704 |
| hsa_XPO1_0014900 | Exon-Exon | chr2:61721029-61726048 | chr2:61493894-61498913 | 655 nt | 0.3664 |
| hsa_XPO1_0015000 | Exon-Exon | chr2:61721029-61727029 | chr2:61493894-61499894 | 837 nt | 0.3656 |
A study in humans demonstrated that circXPO1 is highly expressed in early stages of hepatocellular carcinoma, bladder cancers, and breast cancer, and its decreased expression in myocardial tissues is associated with improved cardiac function after acute myocardial infarction [Sema Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in human coronary artery samples from a single autopsy case demonstrated that circXPO1 was identified as a co-overexpressed circRNA in both the left anterior descending and right coronary artery samples, classifying it as a potential biomarker associated with coronary atherosclerosis [Hou et al. DOI:10.1002/jcla.23552].